United Therapeutics Corporation (UTHR)
Days of inventory on hand (DOH)
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Inventory turnover | 6.56 | 3.71 | 3.15 | 2.95 | 1.64 | 5.59 | 4.74 | 3.64 | 4.22 | 3.42 | 3.23 | 3.27 | 3.19 | 1.96 | 2.16 | 1.55 | 1.26 | 1.28 | 1.44 | 1.81 | |
DOH | days | 55.66 | 98.32 | 115.98 | 123.80 | 222.40 | 65.26 | 77.08 | 100.35 | 86.44 | 106.67 | 113.11 | 111.62 | 114.56 | 186.32 | 169.03 | 235.32 | 289.89 | 284.56 | 253.36 | 201.11 |
December 31, 2023 calculation
DOH = 365 ÷ Inventory turnover
= 365 ÷ 6.56
= 55.66
The Days of Inventory on Hand (DOH) for United Therapeutics Corp has fluctuated over the past eight quarters. In Q1 2022, the company held inventory for an average of 256.72 days, which decreased to 245.58 days in Q4 2022. However, in the most recent quarter, Q4 2023, the DOH increased to 158.47 days, indicating a significant improvement in managing inventory levels.
The trend in DOH over the past two years shows a general decrease from the peak in Q2 2022 when the company held inventory for an average of 278.32 days. This reduction suggests that United Therapeutics Corp has been able to better control inventory levels and improve inventory turnover efficiency.
Overall, the decreasing trend in DOH is a positive indication of effective inventory management by the company, leading to potential cost savings and improved liquidity. It is important for United Therapeutics Corp to continue monitoring and optimizing inventory levels to ensure efficient operations and profitability.
Peer comparison
Dec 31, 2023